Michael V. Ortiz
Impact in
- Ophthalmology top 10%
- Ocular Oncology and Treatments
-
- Lipid metabolism and biosynthesis
Papers in
-
- Renal and related cancers 7
-
- Sarcoma Diagnosis and Treatment 8
- Renal cell carcinoma treatment 3
- Co-authors
- Ira J. Dunkel (2 shared papers)Alex Kentsis (7 shared papers)Stephen S. Roberts (4 shared papers)Neerav Shukla (6 shared papers)Julia Glade Bender (6 shared papers)Hanan Baker (1 shared paper)Leonard H. Wexler (6 shared papers)Daniel A. Heller (1 shared paper)
- Journals
- Pediatric Blood & Cancer (9 papers)Journal of Clinical Oncology (7 papers)Journal of Pediatric Hematology/Oncology (3 papers)Neurosurgery (2 papers)JCI Insight (2 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Michael V. Ortiz
46 papers receiving 694 citations
Peers
Comparison fields: 5 of 98
- Ophthalmology 46
- Biochemistry 33
- Cancer Research 59
- Molecular Biology 280
- Oncology 84
Countries citing papers authored by Michael V. Ortiz
This map shows the geographic impact of Michael V. Ortiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. Ortiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. Ortiz more than expected).
Fields of papers citing papers by Michael V. Ortiz
This network shows the impact of papers produced by Michael V. Ortiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. Ortiz. The network helps show where Michael V. Ortiz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael V. Ortiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 81 | |
| 2 | 2013 | 76 | |
| 3 | 2019 | 69 | |
| 4 | 2019 | 57 | |
| 5 | 1996 | 55 | |
| 6 | 2013 | 47 | |
| 7 | 2016 | 31 | |
| 8 | 2020 | 30 | |
| 9 | Heparin-induced hyperkalemia: a prospective study. | 1991 | 25 |
| 10 | 2008 | 21 | |
| 11 | 2016 | 21 | |
| 12 | 2022 | 19 | |
| 13 | 2022 | 19 | |
| 14 | 2019 | 17 | |
| 15 | 2009 | 16 | |
| 16 | 2021 | 12 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2020 | 8 |
About Michael V. Ortiz
Michael V. Ortiz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Neurology, Surgery and Oncology, having authored 53 papers that have together received 708 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (8 papers), Renal and related cancers (7 papers), Neuroblastoma Research and Treatments (4 papers), Renal cell carcinoma treatment (3 papers), Plant Molecular Biology Research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Anesthesia and Pain Management (2 papers) and Cerebrospinal fluid and hydrocephalus (2 papers). The work is most often cited by research in Ophthalmology (46 citations), Biochemistry (33 citations), Cancer Research (59 citations), Molecular Biology (280 citations) and Oncology (84 citations). Michael V. Ortiz has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Ira J. Dunkel, Alex Kentsis, Stephen S. Roberts, Neerav Shukla, Julia Glade Bender, Hanan Baker, Leonard H. Wexler, Daniel A. Heller, Jackson D. Harvey and J. Fernández Llamazares. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Journal of Pediatric Hematology/Oncology, Neurosurgery and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.